🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
Cytomegalovirus (CMV) infection remains one of the most frequent infectious...
Status
Active Not Recruiting
Location
Universidad de Guadalajara
Start Date
2024-03-01
Trial ID
NCT07430683
Treatments Being Tested
The purpose of this study is to confirm a significant influence of ezetimib...
Status
Completed
Location
Department of Clinical Pharmacology
Start Date
2007-09
Trial ID
NCT00621699
This phase II trial studies the side effects and best dose of bortezomib wh...
Status
Completed
Location
M D Anderson Cancer Center
Start Date
2007-02-13
Trial ID
NCT00439556
A comparative trial where all patients will receive daily doses of tacrolim...
Status
Completed
Location
H. Lee Moffitt Cancer Center & Research Institute
Start Date
2005-09
Trial ID
NCT00360685
The primary aim of this protocol is to evaluate if the one-year survival is...
Status
Terminated
Location
St. Jude Children's Research Hospital
Start Date
2012-08
Trial ID
NCT01621477
This is an in-vivo study to investigate the bioequivalence of generic tacro...
Status
Completed
Location
BioPharma Services USA
Start Date
2021-01-05
Trial ID
NCT04725682
Treatments Being Tested
This phase II clinical trial studies how well treosulfan and fludarabine ph...
Status
Completed
Location
Children's Hospital Colorado
Start Date
2009-07-31
Trial ID
NCT00919503
The objective of this study is to observe and evaluate the change in renal ...
Status
Terminated
Location
KR00001
Start Date
2010-05
Trial ID
NCT02963103
Treatments Being Tested
In this study, participants with high-risk hematologic malignancies undergo...
Status
Terminated
Location
St. Jude Children's Research Hospital
Start Date
2014-07-11
Trial ID
NCT02199041
This phase I/II trial studies the best dose and side effects of gemcitabine...
Status
Terminated
Location
M D Anderson Cancer Center
Start Date
2012-11-21
Trial ID
NCT01629511